Log In
Print
BCIQ
Print
Print this Print this
 

Azor, Sevikar (CS-8663)

  Manage Alerts
Collapse Summary General Information
Company Daiichi Sankyo Co. Ltd.
DescriptionFixed-dose combination of olmesartan, an angiotensin II receptor blocker, and amlodipine, a dihydropyridine calcium channel blocker
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1) ; Calcium channel
Mechanism of ActionAngiotensin II type 1 (AT1) receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsInitial hypertension treatment in patients likely to need multiple antihypertensive agents to achieve blood pressure goal; Treat essential hypertension; Treat hypertension
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today